ASCO 2018 Updates for Sarcomas

Dear readers, Just having returned from a particularly exhilarating annual ASCO meeting, I wanted to quickly share some of the most exciting results from the sarcoma sessions with all of you. Overall, this year revealed exciting advances in treatment of desmoid tumors, as well as PVNS.  Additionally, we learned some important information about oral chemotherapy … Continue reading ASCO 2018 Updates for Sarcomas

Updates from ASCO 2016: Immunotherapy for sarcoma shows a signal!

Greetings from Chicago, where once again, immunotherapy remains the highlight of most ASCO presentations.  This year was particularly exciting, as we finally got to see the preliminary results of the first clinical trials of checkpoint inhibitors for sarcomas.  So, I will update all of you on the most recent data, explain how we still have more … Continue reading Updates from ASCO 2016: Immunotherapy for sarcoma shows a signal!